These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 677887)
1. Synthesis and properties of delta-N-(phosphonacetyl)-L-ornithine. A transition-state analog inhibitor of ornithine transcarbamylase. Hoogenraad NJ Arch Biochem Biophys; 1978 May; 188(1):137-44. PubMed ID: 677887 [No Abstract] [Full Text] [Related]
2. Effect of the transition-state analogue, delta-N-(phosphonacetyl)-L-ornithine on citrulline synthesis in isolated rat-liver mitochondria and on urea synthesis in isolated rat hepatocytes. Hoogenraad NJ; Sutherland TM; Howlett GJ Eur J Biochem; 1979 Oct; 100(1):309-15. PubMed ID: 488100 [No Abstract] [Full Text] [Related]
3. N delta-(phosphonacetyl)-L-ornithine, a potent transition state analogue inhibitor of ornithine carbamoyltransferase. Mori M; Aoyagi K; Tatibana M; Ishikawa T; Ishii H Biochem Biophys Res Commun; 1977 Jun; 76(3):900-4. PubMed ID: 901452 [No Abstract] [Full Text] [Related]
4. The illicit permeation of N-delta-phosphonoacetyl-L-ornithine under the form of a tripeptide. Selective inhibition in vivo of Escherichia coli L-ornithine carbamoyltransferase [proceedings]. Penninckx M; Gigot D Arch Int Physiol Biochim; 1979 Feb; 87(1):198-9. PubMed ID: 92272 [No Abstract] [Full Text] [Related]
5. Mitochondrial carbamyl phosphate and citrulline synthesis at high matrix acetylglutamate. Cohen NS; Cheung CW; Kyan FS; Jones EE; Raijman L J Biol Chem; 1982 Jun; 257(12):6898-907. PubMed ID: 7085611 [TBL] [Abstract][Full Text] [Related]
6. Synthesis of a peptide form of N-delta-(phosphonoacetyl)-L-ornithine. Its antibacterial effect through the specific inhibition of Escherichia coli L-ornithine carbamoyltransferase. Penninckx M; Gigot D J Biol Chem; 1979 Jul; 254(14):6392-6. PubMed ID: 376531 [TBL] [Abstract][Full Text] [Related]
7. Synthesis and interaction with Escherichia coli L-ornithine carbamolytransferase of two potential transition-state analogues. Penninckx M; Gigot D FEBS Lett; 1978 Apr; 88(1):94-6. PubMed ID: 346377 [No Abstract] [Full Text] [Related]
9. Analysis of the control of citrulline synthesis in isolated rat-liver mitochondria. Wanders RJ; Van Roermund CW; Meijer AJ Eur J Biochem; 1984 Jul; 142(2):247-54. PubMed ID: 6745275 [TBL] [Abstract][Full Text] [Related]
10. Further evidence for a separate enzymic entity for the synthesis of homocitrulline, distinct from the regular ornithine transcarbamylase. Carter AL; Eller AG; Rufo S; Metoki K; Hommes FA Enzyme; 1984; 32(1):26-36. PubMed ID: 6434302 [TBL] [Abstract][Full Text] [Related]
11. Purification and properties of porcine liver ornithine transcarbamylase. Koger JB; Howell RG; Kelly M; Jones EE Arch Biochem Biophys; 1994 Mar; 309(2):293-9. PubMed ID: 8135541 [TBL] [Abstract][Full Text] [Related]
12. Substrate inhibition of ornithine carbamoyltransferase and ornithine-ketoacid aminotransferase from rat liver. Shimbayashi K; Umemura Y Natl Inst Anim Health Q (Tokyo); 1972; 12(4):213-21. PubMed ID: 4661195 [No Abstract] [Full Text] [Related]
13. Sparse-fur mutation: a model for some human ornithine transcarbamylase deficiencies. Briand P; Cathelineau L Adv Exp Med Biol; 1982; 153():185-94. PubMed ID: 6819764 [No Abstract] [Full Text] [Related]